News updates

First experiences with an ADR report clinical documentation tool

As part of the WEB-RADR project, Lareb developed a tool (ClinDoc) to measure the level of clinical information in adverse drug...

Open day for patient organisations

In order to strengthen the bond between patient organisations and the pharmacovigilance centre, Lareb held an open day for representatives from patient orga...

Teratogenicity of Second Generation Anti epileptic Drugs

When women with epilepsy want to start a family, they and their treating medical specialists are faced with a difficult problem. A pre...

The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015

Patient reports contribute to signal detection. This was demonstrated by a study b...

New method to gain information about drug effectiveness and ADRs

Lareb and the Netherlands Institute for Health Services Research NIVEL collaborate in a project to develop a method to quickly...

A Student-Run Pharmacovigilance Programme

A programme in which students assess real life reports of adverse drug reactions (ADRs) seems effective to increase knowledge and awareness about ADR...

Quality of clinical information in ADR reports

Patients report clinical information at a similar level as their healthcare professionals. However, since patients and healthcare professionals ...

Abdominal pain, chest pain and headache in SmPC of noscapine

The Adverse Drug Reactions (ADRs) (upper) abdominal pain, chest pain and headache should be added to the Summary of Product Charac...

Mesalazine and sensitivity to sunlight

The Netherlands Pharmacovigilance Centre Lareb received five reports of hypersensitivity to sunlight (photosensitivity) when using the drug mesalazine. ...